StopUMTS Logo
how to get rid of moles 
Zoeken
   
Voorlichting
16/01/18Toon : de 'slimme' thermo
14/01/18Medical Dictionary; micro
Artikelen
19/01/18Home networking explained
19/01/18Home networking explained
14/01/18Can Cell Phones Cause Fem
14/01/18Wetenschappers binden str
12/01/18Apple: Open letter from J
12/01/18Studenten die vaker met s
Berichten Nederland
18/01/18Unlimited 4G voor thuis g
17/01/18Vergaderlocatie / cursusr
14/01/18Ziek van Straling; Fotose
12/01/18Stripheldenbuurt wil geen
12/01/18Stijging aantal euthanasi
Berichten België
18/01/18Aartselaar / Reet: Buren
10/01/18Vereniging ElektroHyperSe
Berichten Internationaal
15/01/18Frankrijk pakt belabberde
12/01/18Oostenrijk: Richtlijnen v
12/01/18Frankreich verordnet Stra
09/01/18USA: CDPH Cell Phone Safe
Ervaringen | Appellen/oproepen
15/01/18Ziekmakende ervaringen me
12/01/18Soms is tinnitus geen tin
12/01/18Bijnier probleem met smar
Onderzoeken
03/01/18EMFs + Wildlife
29/12/17Radiofrequency EMFs and H
19/12/17624 wetenschappelijke
Veel gestelde vragen
13/05/17Vakantie? Witte zo
10/07/16Zeven veel gestelde vrage
Juridische informatie
19/01/18Afspraken voor beterere t
01/01/18Antennebeleid op basis va
15/12/17(Persbericht) Phonegate:
Oproepen
10/12/17Haarlem: Raadsmarkt ZENDM
11/11/17Cursus ‘Straling meten
29/10/17Petitie: Geen uitbreiding
Folders
10/09/17Brochures, folders, websi
29/04/16USA: Meer dan 50 tips voo
Briefwisselingen | Archief: 2008, 2005
19/01/18Brief aan Agentschap Tele
18/01/18Brief naar de gemeente Ut
Illustraties
 Algemeen
 Fotoalbum zendmasten
 Wetenschappelijke illustraties
USA/Frankrijk/Brazilië: Zwakke EMV blijken effectief bij de behandeling van o.a. levertumoren.    
Ga naar overzicht berichten in: Onderzoeken

USA/Frankrijk/Brazilië: Zwakke EMV blijken effectief bij de behandeling van o.a. levertumoren.
zondag, 04 december 2011 - Dossier: Algemeen


Zwakke EMV met specifieke frequentiemodulaties blijken effectief bij de behandeling van levertumoren, eierstokkanker en borstkanker bij veldsterkten ver beneden de op warmte-effecten gebaseerde normen. De onderzoekers hebben geen bio-fysische verklaring voor de effecten, het werkingsmechanisme is onbekend:

Bron: British Medical Journal 9 aug. 2011 en 1 dec 2011

Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields

F P Costa1, A C de Oliveira1, R Meirelles1, M C C Machado1, T Zanesco1, R Surjan1, M C Chammas2, M de Souza Rocha2, D Morgan3, A Cantor4, J Zimmerman5, I Brezovich6, N Kuster7, A Barbault8 and B Pasche5

1 Department of Transplantation and Liver Surgery, Hospital das Clínicas da Faculdade de Medicina, University of São Paulo, Av. Dr. Enéas de Carvalho Aguiar, 255, São Paulo 05403-000, Brazil

2 Department of Radiology, Hospital das Clínicas, University of São Paulo, São Paulo 05403-000, Brazil

3 Department of Radiology, University of Alabama at Birmingham and UAB Comprehensive Cancer Center, Birmingham, AL 35294, USA

4 Biostatistics and Bioinformatics Shared Facility, University of Alabama at Birmingham and UAB Comprehensive Cancer Center, Birmingham, AL 35294, USA

5 Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham and UAB Comprehensive Cancer Center, 1802 6th Ave South, NP 2566, Birmingham, AL 35294-3300, USA

6 Department of Radiation Oncology, The University of Alabama at Birmingham and UAB Comprehensive Cancer Center, Birmingham, AL 35294, USA

7 IT'IS Foundation, Swiss Federal Institute of Technology, Zurich, Switzerland
8Rue de Verdun 20, Colmar 68000, France

Correspondence:
Dr FP Costa, E-mail: fredericoperegocosta@gmail.com;
Dr B Pasche, E-mail: Boris.Pasche@ccc.uab.edu

Therapeutic options for patients with advanced hepatocellular carcinoma (HCC) are limited. There is emerging evidence that the growth of cancer cells may be altered by very low levels of electromagnetic fields modulated at specific frequencies.

Methods:

A single-group, open-label, phase I/II study was performed to assess the safety and effectiveness of the intrabuccal administration of very low levels of electromagnetic fields amplitude modulated at HCC-specific frequencies in 41 patients with advanced HCC and limited therapeutic options. Three-daily 60-min outpatient treatments were administered until disease progression or death. Imaging studies were performed every 8 weeks. The primary efficacy end point was progression-free survival greater than or equal to6 months. Secondary efficacy end points were progression-free survival and overall survival.

Results:

Treatment was well tolerated and there were no NCI grade 2, 3 or 4 toxicities. In all, 14 patients (34.1%) had stable disease for more than 6 months. Median progression-free survival was 4.4 months (95% CI 2.1–5.3) and median overall survival was 6.7 months (95% CI 3.0–10.2). There were three partial and one near complete responses.

Conclusion:

Treatment with intrabuccally administered amplitude-modulated electromagnetic fields is safe, well tolerated, and shows evidence of antitumour effects in patients with advanced HCC.

Voor het originele abstract zie:
www.nature.com/bjc/journal/v105/n5/abs/bjc2011292a.html .

en voor de sceptici zie het follow-up paper van 1 dec 2011:
www.nature.com/bjc/journal/vaop/ncurrent/abs/bjc2011523a.html .

Voor een deskundig Engelstalig commentaar bij deze verbazingwekkende ontdekking zie:
www.microwavenews.com/ModulationFrequencies.html .


Ga terug naar het hoofdmenu
Afdrukken | Vragen | RSS | Disclaimer